logo

For the Inventor, By the Inventor

Notre Dame De Bondeville, France

Jean-Christophe Plaquevent

This inventor holds 12 USPTO granted patents, plus 1 CIPO patent. Top assignees: Societe Civile Bioprojet, Bioprojet, National Institute of Health and Medical Research. Active years: 1992-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Christophe Plaquevent. Retrieved from https://idiyas.com/inventor/jean-christophe-plaquevent

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 75.0


Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 198(Granted Patents)


Location History:

  • Deville les Rouen, FR (2000)
  • Notre Dame De Bondeville, FR (1992 - 2006)

Company Filing History:

goldMedal8 out of 20 
 
Societe Civile Bioprojet
 patents
silverMedal2 out of 24 
 
Bioprojet
 patents
bronzeMedal2 out of 1,853 
 
National Institute of Health and Medical Research
 patents
4. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2006

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 7094773 - [object Object] (2006-08-22),
2. 6878723 - LTA4 hydrolase inhibitors (2005-04-12),
3. 6835851 - Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids (2004-12-28),
4. 6436973 - LTA4 hydrolase inhibitors (2002-08-20),
5. 6013829 - Process for the asymmetric synthesis of S-acyl derivatives of (2000-01-11),
6. 5846956 - Amino acids derivatives, the process for their preparation and their (1998-12-08),
7. 5670531 - Amino acid derivatives, the process for their preparation and their (1997-09-23),
8. 5599951 - Amino acid derivatives, the process for their preparation and their (1997-02-04),
9. 5331008 - Thioester enantiomeric compounds and their therapeutic uses (1994-07-19),
10. 5296509 - Thioester enantiomeric compounds and their therapeutic uses (1994-03-22),
11. 5208255 - Thioester enantiomeric compounds and their therapeutic uses (1993-05-04),
12. 5136076 - Process for the preparation of amino acid-derived enatiomeric compounds (1992-08-04),

Title: Innovative Contributions of Jean-Christophe Plaquevent

Introduction: Jean-Christophe Plaquevent is a notable inventor from Notre Dame De Bondeville, France. With a remarkable portfolio of 12 patents, he has made significant advancements in the field of medicinal chemistry, particularly in anti-inflammatory compounds.

Latest Patents: Among his latest innovations, one prominent patent involves compounds that exhibit anti-inflammatory activity by inhibiting leukotriene A (LTA). This enzyme plays a crucial role in the biosynthesis of leukotriene LTB, which is a principal pro-inflammatory mediator. The invention not only details these compounds but also explores their therapeutic anti-inflammatory applications and methods for their preparation. Another notable patent addresses compounds that inhibit LTA4 hydrolase, which are of significant therapeutic interest, especially in treating inflammation.

Career Highlights: Throughout his career, Jean-Christophe has worked with esteemed organizations including Société Civile Bioprojet and Bioprojet. His contributions to medicinal chemistry and his innovative solutions have positioned him as a key figure in the development of effective anti-inflammatory treatments.

Collaborations: In his journey, Jean-Christophe has collaborated with distinguished professionals such as Denis Danvy and Pierre Duhamel. These partnerships have fostered an environment of innovation, enhancing his research and development efforts.

Conclusion: Jean-Christophe Plaquevent stands out as a prolific inventor whose work continues to influence the field of anti-inflammatory therapeutics. His inventive spirit and dedication to solving complex medical challenges have made a lasting impact, paving the way for future innovations in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…